Compare Crocs, Inc. (CROX) vs Inovio Pharmaceuticals Inc (INO) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Crocs, Inc. vs Inovio Pharmaceuticals Inc — how do they compare? Crocs, Inc. trades at $131.61 (market cap $6.31B), while Inovio Pharmaceuticals Inc trades at $0.8 (market cap $78.55M). The key difference: Crocs, Inc. is far larger — about 80.3× Inovio Pharmaceuticals Inc's market cap, and Crocs, Inc. is trading nearer its 52-week high, Inovio Pharmaceuticals Inc nearer its low. Which is the better fit depends on your goals.
| CROX | INO | |
|---|---|---|
Market Cap | $6.31B | $78.55M |
Sector | Consumer Staples | Health |
52-Week High | $141.19 | $2.87 |
52-Week Low | $73.39 | $0.66 |
Enterprise Value | $7.83B | $49.56M |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Crocs, Inc.
Crocs Inc is engaged in the design, development, marketing, distribution, and sale of casual lifestyle footwear accessories for men, women, and children. The reportable geographic segments of the company include Americas, Asia pacific, and EMEA.
Read more on CROX →About Inovio Pharmaceuticals Inc
Inovio Pharmaceuticals Inc is a United States based biotechnology company that develops active DNA-based immunotherapies and vaccines to treat and prevent cancers and infectious diseases. The company is engaged in gene therapy, where its immunotherapy platform consists of DNA-based immunotherapy and electroporation delivery technologies.
Read more on INO →
